By facilitating inclusive, reproducible, and real-time access to pathway-specific insights, AI-HOPE-TP53 represents a scalable, open-access computational resource for cancer researchers working across disciplines, from translational science to epidemiology, with the potential to advance both discovery and health equity in precision oncology for CRC. This evidence concerns the gene TP53 and cancer.